Tower Research Capital LLC (Trc) C4 Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

  • $3.39 Billion
  • Q3 2025

A detailed history of Tower Research Capital LLC (Trc) transactions in C4 Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 8,414 shares of CCCC stock, worth $20,782. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,414
Previous 40,592 79.27%
Holding current value
$20,782
Previous $58,000 68.97%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$1.47 - $3.57 $47,301 - $114,875
-32,178 Reduced 79.27%
8,414 $18,000
Q2 2025

Aug 14, 2025
BUY
$1.1 - $1.74 $36,648 - $57,971
33,317 Added 457.97%
40,592 $58,000
Q1 2025

May 15, 2025
SELL
$1.6 - $4.09 $5,918 - $15,128
-3,699 Reduced 33.71%
7,275 $11,000
Q4 2024

Feb 13, 2025
SELL
$3.6 - $7.0 $45,799 - $89,054
-12,722 Reduced 53.69%
10,974 $39,000
Q3 2024

Nov 14, 2024
BUY
$4.43 - $7.38 $8,204 - $13,667
1,852 Added 8.48%
23,696 $135,000
Q2 2024

Aug 13, 2024
BUY
$4.05 - $8.1 $60,470 - $120,941
14,931 Added 215.98%
21,844 $100,000
Q1 2024

May 15, 2024
SELL
$5.3 - $11.0 $49,867 - $103,499
-9,409 Reduced 57.65%
6,913 $56,000
Q4 2023

Feb 13, 2024
BUY
$1.18 - $6.03 $4,794 - $24,499
4,063 Added 33.14%
16,322 $92,000
Q3 2023

Nov 14, 2023
BUY
$1.81 - $3.89 $5,207 - $11,191
2,877 Added 30.67%
12,259 $22,000
Q2 2023

Aug 14, 2023
BUY
$2.75 - $3.77 $15,251 - $20,908
5,546 Added 144.58%
9,382 $25,000
Q1 2023

May 09, 2023
BUY
$3.1 - $9.02 $7,250 - $21,097
2,339 Added 156.25%
3,836 $12,000
Q4 2022

Feb 10, 2023
SELL
$5.42 - $10.24 $46,628 - $88,094
-8,603 Reduced 85.18%
1,497 $9,000
Q3 2022

Nov 10, 2022
BUY
$8.03 - $12.77 $58,362 - $92,812
7,268 Added 256.64%
10,100 $89,000
Q2 2022

Aug 15, 2022
SELL
$5.06 - $26.46 $41,512 - $217,077
-8,204 Reduced 74.34%
2,832 $21,000
Q1 2022

May 12, 2022
BUY
$19.99 - $33.23 $124,117 - $206,325
6,209 Added 128.63%
11,036 $268,000
Q4 2021

Feb 14, 2022
BUY
$29.39 - $46.86 $58,868 - $93,860
2,003 Added 70.93%
4,827 $155,000
Q3 2021

Nov 15, 2021
BUY
$35.91 - $50.5 $60,328 - $84,840
1,680 Added 146.85%
2,824 $126,000
Q2 2021

Aug 16, 2021
SELL
$30.39 - $42.18 $28,323 - $39,311
-932 Reduced 44.89%
1,144 $44,000
Q1 2021

May 17, 2021
BUY
$31.96 - $46.5 $57,208 - $83,235
1,790 Added 625.87%
2,076 $76,000
Q4 2020

Feb 16, 2021
BUY
$22.8 - $37.05 $6,520 - $10,596
286 New
286 $9,000

Others Institutions Holding CCCC

# of Institutions
109
Shares Held
55.4M
Call Options Held
329K
Put Options Held
186K
View Full List

About C4 Therapeutics, Inc.

CCCC Quotes by TradingView
  • Ticker CCCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,913,800
  • Market Cap $121M
  • Description
  • C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...
More about CCCC
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email